An analysis of T cell antigen receptor variable β genes during the clinical course of patients with chronic hepatitis B

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 4, 1999, Pages 333-338

  Sugyo, Shinya ^a   Yuh, Kouichi ^a   Nakamura, Ken ^a   Emi, Kanako ^a   Shijo, Hiroshi ^a   Iida, Takeshi ^a   Kimura, Nobuhiro ^a   Tamura, Kazuo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Activation induced cell death; Hepatitis B virus; Reverse transcriptase polymerase chain reaction; T cell antigen receptor variable gene

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FOLLOW UP; GENE; GENE EXPRESSION; HEPATITIS B; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033372773     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01854.x     Document Type: Article

References (32)

1. 1 Millich DR. Immune response to hepatitis B virus proteins. Relevance of the murine model. Semin. Liver. Dis. 1991; 11: 93-112.
2. 2 Tsai SL, Chen PJ, Lai MY et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J. Clin. Invest. 1992; 89: 87-96.
3. 3 Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N, Okumura M. Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology 1996; 111: 156-64.
4. 4 Paliard X, West SG, Lafferty JA et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253: 325-9.
5. 5 Conrad B, Weidman E, Trucco G et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371: 351-5.
6. 6 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 1987; 162: 156-9.
7. 7 Kimura N, Toyonaga B, Yoshikai Y, Du RP, Mak TW. Sequences and repertoire of the human T-cell receptor a and β chain variable region genes in thymocytes. Eur. J. Immunol. 1987; 17: 375-83.
8. 8 Kimura N, Toyonaga B, Yoshikai Y et al. Sequences and diversity of human T cell receptor β chain variable region genes. J. Exp. Med. 1986; 164: 739-50.
9. 9 Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proc. Natl Acad. Sci. USA 1989; 86: 8941-5.
10. 10 Ben-Nun A, Liblau RS, Cohen L et al. Restricted T-cell receptor V beta usage by myelin basic protein-specific T-cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc. Natl Acad. Sci. USA 1991; 88: 2466-70.
11. 11 Sambrook J, Fritsch EF, Maniatis T. Analysis and cloning of eukariotic genomic DNA. In: Nolan C, ed. Molecular Cloning. Vol 2. 2nd edn. New York: Cold Spring Harbor Press, 1989: 9-58.
12. 12 Wysocki LJ, Sato VL. 'Panning' for lymphocytes: A method for cell selection. Proc. Natl Acad. Sci. USA 1978; 75: 2844-8.
13. 13 Miyanohara A, Toh-E A, Nozaki C, Hamada F, Ohtomo N, Matsubara K. Expression of hepatits B surface antigen in yeast. Proc. Natl Acad. Sci. USA 1983; 80: 1-5.
14. 14 Caignard A, Dietrich PY, Morand V et al. Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck. Cancer. Res. 1994; 54: 1292-7.
15. 15 Yuh K, Sugyo S, Nakamura K et al. Analysis of human T-cell antigen receptor variable β gene usage following vaccination with recombinant HBsAg. Digest. Dis. Sci. 1998; 43: 880-6.
16. 4 T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994; 370: 463-7.
17. 17 Herman A, Kappler JW, Marrack P, Pullen AM. Superantigens: Mechanism of T-cell stimulation and role in immune responses. Ann. Rev. Immunol. 1991; 9: 745-72.
18. 18 Kayser C, Waase I, Weyand CM, Goronzy JJ. T cell receptor germline gene segments and HLA haplotypes control the length of the CDR3 of human T cell receptor β chains. Cell. Immunol. 1996; 168: 235-42.
19. 19 Abe J, Kotzin BL, Jujo K et al. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc. Natl Acad. Sci. USA 1992; 89: 4066-70.
20. 20 Liblau RS, Tisch R, Shokat K et al. Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis. Proc. Natl Acad. Sci. USA 1996; 93: 3031-6.
21. 21 Critchfield JM, Racke MK, Zuniga-Pflucker JC et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139-43.
22. 22 Russell JH, White CL, Loh DY, Meleedy-Rey P. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl Acad. Sci. USA 1991; 88: 2151-5.
23. 23 Ucker DS, Meyers J, Obermiller PS. Activation-driven T cell death. 2. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J. Immunol. 1992; 149: 1583-92.
24. 2 4 Owen-Schaub LB, Yonehara S, Crump WL III, Grim EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 1992; 140: 197-205.
25. 25 Anel A, Buferne M, Boyer C, Schmitt-Vehulst A-M, Golstein P. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 1994; 24: 2469-76.
26. 26 Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 1995; 181: 781-6.
27. 27 Bertoletti A, Sette A, Chisari FV et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369: 407-10.
28. 28 Lanzavecchia A. Identifying strategies for immune intervention. Science 1993; 260: 937-44.
29. 29 Nelson CA, Petzold SJ, Unanue ER. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 1994; 371: 250-2.
30. 30 Saha K, Yuen PH, Wong PKY. Murine retrovirus-induced depletion of T cells is mediated through activation-induced death by apoptosis. J. Virol. 1994; 68: 2735-40.
31. 31 Casini A, Alberti A, Banchetti E et al. Cell-mediated immunity to HBcAg in chronic HBV infection. Am. J. Clin. Pathol. 1987; 88: 494-8.
32. 32 Lechmann M, Ihlenfeldt HG, Braunschweiger I et al. T-and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology 1996; 24: 790-5.